These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37910782)
1. Inhibition of keloid by Xie L; Huang L; Zhang G; Su Y Aging (Albany NY); 2023 Oct; 15(21):11985-11993. PubMed ID: 37910782 [TBL] [Abstract][Full Text] [Related]
2. Activating transcription factor 3 (ATF3) regulates cell growth, apoptosis, invasion and collagen synthesis in keloid fibroblast through transforming growth factor beta (TGF-beta)/SMAD signaling pathway. Wang XM; Liu XM; Wang Y; Chen ZY Bioengineered; 2021 Dec; 12(1):117-126. PubMed ID: 33315500 [TBL] [Abstract][Full Text] [Related]
3. DKK3 regulates cell proliferation, apoptosis and collagen synthesis in keloid fibroblasts via TGF-β1/Smad signaling pathway. Li Y; Liu H; Liang Y; Peng P; Ma X; Zhang X Biomed Pharmacother; 2017 Jul; 91():174-180. PubMed ID: 28458155 [TBL] [Abstract][Full Text] [Related]
4. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway. He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of fibronectin extra domain B suppresses TGF-β1-mediated cell proliferation and collagen deposition in keloid fibroblasts via AKT/ERK signaling pathway. Cui J; Li Z; Jin C; Jin Z Biochem Biophys Res Commun; 2020 Jun; 526(4):1131-1137. PubMed ID: 32317186 [TBL] [Abstract][Full Text] [Related]
6. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation. Zhang T; Wang XF; Wang ZC; Lou D; Fang QQ; Hu YY; Zhao WY; Zhang LY; Wu LH; Tan WQ Biomed Pharmacother; 2020 Sep; 129():110287. PubMed ID: 32540643 [TBL] [Abstract][Full Text] [Related]
7. Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location. Zhao MJ; Chen SY; Qu XY; Abdul-Fattah B; Lai T; Xie M; Wu SD; Zhou YW; Huang CZ Curr Med Sci; 2018 Oct; 38(5):894-902. PubMed ID: 30341526 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of interleukin-10 in keloid fibroblasts by suppression of TGF-β/Smad pathway. Shi CK; Zhao YP; Ge P; Huang GB Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):9085-9092. PubMed ID: 31696499 [TBL] [Abstract][Full Text] [Related]
10. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach. Wu CS; Wu PH; Fang AH; Lan CC Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338 [TBL] [Abstract][Full Text] [Related]
11. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway. Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969 [TBL] [Abstract][Full Text] [Related]
12. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways. Wang W; Qu M; Xu L; Wu X; Gao Z; Gu T; Zhang W; Ding X; Liu W; Chen YL J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758 [TBL] [Abstract][Full Text] [Related]
13. The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid. Chen J; Zeng B; Yao H; Xu J Burns; 2013 May; 39(3):465-72. PubMed ID: 22981800 [TBL] [Abstract][Full Text] [Related]
14. [Effects of interferon-gamma on the transforming growth factor beta/Smad pathway in keloid-derived fibroblasts]. Liu JQ; Hu DH; Zhang ZF; Guan H; She T; Zhang J; Bai XZ Zhonghua Shao Shang Za Zhi; 2009 Dec; 25(6):454-9. PubMed ID: 20193171 [TBL] [Abstract][Full Text] [Related]
15. Mast cell chymase in keloid induces profibrotic response via transforming growth factor-β1/Smad activation in keloid fibroblasts. Dong X; Zhang C; Ma S; Wen H Int J Clin Exp Pathol; 2014; 7(7):3596-607. PubMed ID: 25120737 [TBL] [Abstract][Full Text] [Related]
16. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions. Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007 [TBL] [Abstract][Full Text] [Related]
17. MiR-21 Regulates Keloid Formation by Downregulating Smad7 via the TGF-β/Smad Signaling Pathway. Wu J; Fang L; Cen Y; Qing Y; Chen J; Li Z J Burn Care Res; 2019 Oct; 40(6):809-817. PubMed ID: 31184708 [TBL] [Abstract][Full Text] [Related]
18. Sumoylation enhances the activity of the TGF-β/SMAD and HIF-1 signaling pathways in keloids. Lin X; Wang Y; Jiang Y; Xu M; Pang Q; Sun J; Yu Y; Shen Z; Lei R; Xu J Life Sci; 2020 Aug; 255():117859. PubMed ID: 32474020 [TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways. Tang M; Bian W; Cheng L; Zhang L; Jin R; Wang W; Zhang Y Int J Mol Med; 2018 Mar; 41(3):1487-1499. PubMed ID: 29328420 [TBL] [Abstract][Full Text] [Related]
20. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts. Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]